Robert Letterio Oliva, Director at Novo Integrated Sciences, Inc. (NVOS), bought 13,000 shares at $2.12 ($28K) on 2021-04-21, disclosed to the SEC on 2021-04-23.
Open-market purchase of $28k NVOS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |